AXNX - Axonics' implantable sacral neurostimulator gets European CE mark

Axonics (AXNX) announces European CE Mark approval of its second generation Axonics r-SNM implantable neurostimulator ((INS)) and wireless patient remote control with SmartMRI technology. Axonics previously received FDA approval for this INS and remote control during 2020. This version reduces how frequently a patient needs to recharge their sacral neuromodulation device to just once a month for about one hour.The newly approved remote control simplifies the process by which patients can receive a full-body MRI, avoiding the need to visit physician’s office.

For further details see:

Axonics' implantable sacral neurostimulator gets European CE mark